Enhancers act to regulate cell-type-specific gene expression by facilitating the transcription of target genes. In mammalian cells, active or primed enhancers are commonly marked by monomethylation of histone H3 at lysine 4 (H3K4me1) in a celltype-specific manner. Whether and how this histone modification regulates enhancer-dependent transcription programs in mammals is unclear. In this study, we conducted SILAC mass spectrometry experiments with mononucleosomes and identified multiple H3K4me1-associated proteins, including many involved in chromatin remodeling. We demonstrate that H3K4me1 augments association of the chromatin-remodeling complex BAF to enhancers in vivo and that, in vitro, H3K4me1-marked nucleosomes are more efficiently remodeled by the BAF complex. Crystal structures of the BAF component BAF45C indicate that monomethylation, but not trimethylation, is accommodated by BAF45C's H3K4-binding site. Our results suggest that H3K4me1 has an active role at enhancers by facilitating binding of the BAF complex and possibly other chromatin regulators.
I n cells, cis-regulatory elements such as enhancers and promoters can be defined not only by DNA sequence motifs but also by common and predictive patterns of epigenetic modifications 1 . Active promoters are enriched for H3K4me3 and histone H3 or H4 acetylation along with binding of multiple chromatin regulatory complexes 2 . Primed enhancers are marked by H3K4me1 (coupled with depletion of H3K4me3), whereas active enhancers are enriched for H3K4me1, H3K27ac, and sometimes H4K16ac and H3K122ac [2] [3] [4] [5] [6] [7] [8] . Such epigenetic signatures are commonly used to predict de novo regulatory elements in novel cell types. Numerous studies have demonstrated that H3K4me1 is highly dynamic and correlates well with cell-type-specific gene expression profiles, whereas promoter-associated H3K4me3 is more invariant across cell types 9 .
It has been postulated that specific histone modifications function as binding elements for effector proteins that serve to regulate transcription through manipulation of the chromatin environment or assembly of transcription machinery [10] [11] [12] [13] . For example, promoterassociated H3K4me3 can lead to recruitment of TFIID (through direct interaction with TAF3) to positively regulate transcription 14 .
On the other hand, the function of H3K4me1 at enhancers has not been well understood. Knockout of the H3K4 methyltransferases KMT2C and KMT2D results in a global loss of H3K4me1 and reduces H3K27ac levels as well as binding of Mediator and RNA polymerase II at enhancers 15, 16 . KMT2C and KMT2D (KMT2C/D) double-knockout cells exhibited defects in enhancer activation, cell-type-specific gene expression and differentiation capacities 16, 17 . These studies, while supporting a role for H3K4me1 in enhancer function, did not characterize the mechanism of action of this histone mark. It is likely that H3K4me1 may act by recruiting specific effector proteins.
A recent study of the H3K4 demethylase KDM5C showed that, while H3K4me3 positively regulates transcription at promoters, increased H3K4me3 serves to decrease enhancer function 18 . The correct balance of H3K4me1 and H3K4me3 at promoters is equally important for transcriptional regulation. At promoters, a decrease in H3K4me3 and repression of transcription are coupled with an increase in H3K4me1 in many cell types 19 . Additionally, H3K4me1 is known to block binding of H3K4me3-associated factors such as ING1. In fact, H3K4me1 also demarcates the boundaries of active promoters, thus limiting the recruitment of factors and specifying the promoter region 19 . These closely related modifications seem to have very distinct roles in gene regulatory networks in cells, depending on localization and differential association with regulatory complexes. This fact underscores the need to identify factors that can specifically bind to H3K4me1 and perhaps distinguish between H3K4me1 and H3K4me3, to fully understand the role of this histone modification in gene regulation.
Peptide or nucleosome pulldown coupled with SILAC (stable isotope labeling by amino acids in cell culture) mass spectrometry analysis has been used to identify factors associating specifically with histone tail modifications 14, 20, 21 . Such studies have successfully identified proteins associated with H3K9me1, H3K9me2, H3K9me3, H3K4me3, and H3K27me3. However, in all previous studies, binding of complexes to methylated versus unmethylated histone states was compared. In the current study, we designed a screen to identify candidate H3K4me1 binders while simultaneously comparing association of factors with mononucleosomes bearing the H3K4me1 versus H3K4me3 modification. Our approach identified multiple components of the transcriptional regulatory machinery, including the BAF complex, as enriched for H3K4me1 association. ChIP-seq analysis confirmed that Articles NAturE GENEtICS the binding of these factors to putative enhancers correlates with H3K4me1 across the genome in mouse embryonic stem cells (mESCs). Notably, binding of these H3K4me1-associating proteins was drastically reduced upon depletion of KMT2C/D and loss of H3K4me1 at enhancers. In addition, loss of H3K4me1 in a mutant mESC line bearing catalytic site mutations in KMT2C and KMT2D correlates with reduced binding of BAF components SMARCA4 (BRG1) and DPF2 (BAF45D). We characterized the subunit in the BAF complex involved in preferential recognition of H3K4me1 over H3K4me3 by X-ray crystallographic analysis. We further demonstrated that, in vitro, BAF more efficiently remodels H3K4me1-modified nucleosomes. Taken together, our results provide mechanistic insights into how H3K4me1 acts to regulate the function of enhancers.
Results
Identification of potential H3K4me1 binding partners. We assembled nucleosomes with chemically modified histone H3 and naive histones H4, H2A, and H2B ( Fig. 1a ) [22] [23] [24] [25] . H3K4me1-and H3K4me3-marked nucleosomes were used as bait in pulldowns of nuclear extract prepared from HeLa cells grown in medium containing either light-or heavy-isotope-labeled amino acids ( Fig. 1b) 20 . Any factor specifically associating with H3K4me1 over H3K4me3 in the forward reaction would be detected by mass spectrometry as enriched in peptides with light-isotope-labeled lysine, while it would be enirched in peptides with heavy-isotope-labeled lysine in the reverse reaction ( Fig. 1b ). Multiple replicates were performed with similar results. For final analysis, two replicates were combined and the ratios of light-isotope-labeled peptides to heavyisotope-labeled peptides were averaged across replicates ( Fig. 1c and Supplementary Table 1 ). As we are only assessing H3K4me1 versus H3K4me3 affinity, we cannot rule out the possibility that factors identified as H3K4me1 binders may also associate with H3K4me2 or H3K4me0. Nevertheless, our approach yielded a plethora of putative H3K4me1-associated proteins, including many known chromatin regulators and chromatin-associated factors (Supplementary Table 2 ). Multiple subunits of the BAF (SWI/SNF) complex, such as SMARCA4 (BRG1) and SMARCC1 and SMARCC2 (BAF155 and BAF170), were isolated in the precipitates. Also identified were components of other chromatin-remodeling complexes such as BAZ1B from WINAC and WICH, and BAZ1A from ACF. Many factors isolated contain histone-binding domains (Supplementary Table 2 ) and, in addition, several of these factors have been found associated with H3K4me1-modified regions of the genome in cells by ChIP mass spectrometry 26 . Interestingly, two cohesin subunits were found to be associated with H3K4me1-marked nucleosomes. Cohesin is known to associate with enhancers and to facilitate enhancer-promoter looping 27 . The results implicate H3K4me1 in many facets of enhancer function, from chromatin remodeling to looping of enhancers and promoters. In addition to the H3K4me1associated factors, we identified several new H3K4me3-associated proteins such as the FACT components SSRP1 and SUPT16H.
Our mononucleosome pulldowns differed from previous experiments that largely employed methylated histone tail peptides as bait. For the purpose of comparison, the assay was repeated comparing H3K4me1 and H3K4me3 peptides instead of mononucleosomes, and in this case we observed enrichment of TAF and ING family proteins, as observed by other laboratories 14 . Notably, there was less enrichment of factors for H3K4me1 in the peptide pulldowns as compared to the use of mononucleosome templates. This difference could be due to histone tails adopting a distinct conformation, necessary for substrates to bind, only in the context of intact nucleosomes 28 . Alternatively, it could be due to additional interactions that exist only in intact nucleosome substrates.
To validate the association and identity of a subset of the chromatin regulators (CRs) identified in our screen, we incubated methylated nucleosomes with HeLa nuclear extract and performed western blotting to identify associated factors ( Fig. 1d ). Target validation was limited by the availability of specific antibodies, so we were unable to conduct further analysis on several interesting candidates. However, we confirmed preferential binding of H3K4me1 over H3K4me3 for a number of known enhancer-associated factors. It should also be noted that some proteins bound to multiple methylation states, such as SAP18, which bound to H3K4me1 and H3K4me2, and SMARCC2, which bound to H3K4me0 and H3K4me1 (Fig. 1d ). While some factors have domains known to bind methylated lysine residues, such as the PHD domains found in PHRF1 and BAF components, other factors identified in the screen do not have any known histonebinding domains. It is clear that complex binding patterns of multiple protein complexes are involved.
Chromatin regulators are localized to H3K4me1-rich genomic regions. Next, we performed ChIP-seq for 16 chromatin regulators and 4 histone modification marks in mESCs to determine the localization of the candidate H3K4me1-binding CRs. Clustering analysis of the ChIP-seq profiles of these factors along with three histone H3K4 methylation states (me1, me2, and me3) showed that nearly all of the CRs tested clustered together with H3K4me1 in a branch separate from H3K4me2 and H3K4me3 ( Fig. 2a ). We further assayed binding of the CRs to a subset of previously validated enhancers 29 and negative-control regions by ChIP-qPCR and found CRs to be enriched at all enhancers tested (Fig. 2b,c and Supplementary  Fig. 1a-d ). Enrichment of H3K4me1-associated CRs was observed at a previously validated Sox2 enhancer 30 , and several factors were also enriched at the Sox2 promoter overlapping with the promoterflanking H3K4me1 domains. Interestingly, we observed consistently higher CR enrichment at regions with both H3K4me1 and H3K27ac ( Supplementary Fig. 2c,d ). Next, we investigated CR association with poised (n = 28,008) and active (n = 13,811) enhancer regions, defined as H3K4me1-positive regions with or without concomitant H3K27ac signals. For this specific analysis, 'active' enhancers were defined on the basis of H3K27ac signals and not H4K16ac or H3K122ac. We discovered that active enhancer regions tended to be occupied by multiple CRs, whereas poised enhancer regions showed binding patterns for individual CRs ( Fig. 2d and Supplementary  Fig. 2d , left versus right). The majority of CRs tested bound a high fraction of H3K27ac-containing enhancer regions ( Supplementary  Fig. 1e ). That acetylation of H3K27 at enhancers coincides with binding by multiple co-activators implies that binding of multiple CRs might be necessary for full activation of enhancers.
H3K4me1-dependent association of CRs with enhancers. The above results confirmed the association of CR complexes with H3K4me1 in vitro and in vivo. To determine whether chromatin association of CRs is dependent upon H3K4me1, we carried out ChIP-seq analyses of these protein complexes in mESCs with codeletion of KMT2C and KMT2D 17 . Previous studies have demonstrated that KMT2C and KMT2D are responsible for H3K4me1 deposition at enhancers in multiple species 15, 16 . Consistent with previous data from mouse preadipocytes and human colon cancer cells, knockout of both of these enzymes in mESCs results in a general decrease in H3K4me1 but has little effect on the global level of H3K4me3 17 . We performed H3K4me1, H3K4me2, and H3K4me3 ChIP-seq in mESCs deleted of both the Kmt2c and Kmt2d genes (DKO) and compared the results with data from wild-type (WT) mESCs. We observed that the majority of the H3K4me3 distribution remained unaltered between WT and DKO cells ( Fig. 3c ), whereas H3K4me2 levels were mildly affected ( Fig. 3b and Supplementary Fig. 2a,b ). Consistent with the previous studies, we observed a dramatic reduction in H3K4me1 signal throughout the genome ( Fig. 3a and Supplementary Fig. 2a,b ):
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47% of H3K4me1 peaks detected in WT mESCs were lost in DKO mESCs ( Fig. 3d and Supplementary Fig. 2c ). KMT2C/D-dependent H3K4me1 peaks were enriched at enhancers ( Fig. 3d) , consistent with the previously suggested function of KMT2C and KMT2D at these sites 15, 16 . KMT2C/D-independent H3K4me1 peaks, on the other hand, overlapped not only with enhancers but also with promoters ( Fig. 3d ). We also detected H3K4me2 peaks that were both dependent and independent of KMT2C and KMT2D expression ( Supplementary Fig. 2d ). However, in contrast to H3K4me1 peaks, KMT2C/D-dependent H3K4me2 was found at both enhancers and promoters in equal proportions. Additionally, as seen in preadipocytes, KMT2C/D-dependent loss of H3K4me1 coincided with a moderate decrease in H3K27ac at the same regions ( Fig. 3e and Supplementary Fig. 2a,b) .
Peaks that were dependent and independent of KMT2C and KMT2D were both bound by CRs, but the fraction of associated peaks was highly variable (Fig. 3f ). CRs could be reduced at KMT2C/D-dependent sites in DKO cells if H3K4me1 acts to facilitate or stabilize their binding. To test this hypothesis, we performed ChIP-seq for a subset of the H3K4me1-associated CRs and 
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demonstrated an overlap with H3K4me1 occupancy in WT cells. All CRs tested were reduced at KMT2C/D-dependent H3K4me1 sites as compared to KMT2C/D-independent sites in the DKO mESCs ( Fig. 3f and Supplementary Fig. 2 ). We obtained similar results assessing CR association with known mESC enhancers using ChIP-qPCR ( Supplementary Fig. 2e ). 
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A recent study by Dorighi et al. highlights a role for KMT2C and KMT2D in transcriptional regulation independent of H3K4me1 deposition 31 . Our data suggest that H3K4me1 is important for CR binding; however, this new study raised the possibility that loss of KMT2C/D could directly affect binding of CRs independently of H3K4me1 loss. We therefore used a KMT2C/D catalytically inactive cell line (dCD) to distinguish the roles of H3K4me1 and KMT2C/D in binding of CRs. We performed ChIP-seq for H3K4me marks, H3K27ac, and BAF complex components SMARCA4 (BRG1) and DPF2 (BAF45D) (Fig. 4a) . In dCD cells, 38% of the distal H3K4me1 sites had reduced levels of H3K4me1. Interestingly, a small fraction of H3K4me1 sites also gained H3K4me1 signal, which is consistent 
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with the previous data 31 , and these sites are located closer to promoters than the H3K4me1-depleted regions. As in DKO cells, H3K4me2 and H3K4me3 levels were less affected than those of H3K4me1 (Fig. 4b-d and Supplementary Fig. 3b ). At regions where we observed specific loss of H3K4me1 signal, we likewise observed a decrease in binding of both SMARCA4 and DPF2 (Fig. 4e,f and Supplementary Fig. 3c,d) . Reduced BAF complex binding was specific for sites where H3K4me1 was depleted ( Fig. 4f) and was not seen at sites where H3K4me1 was unchanged, indicating that H3K4me1 facilitates BAF complex binding to these regions. Taken together, our data from KMT2C/D DKO cells and cells with catalytically inactive KMT2C/D support the hypothesis that H3K4me1 has an important role in binding of multiple CR complexes to enhancers.
BAF complex preferentially binds to and remodels H3K4me1marked nucleosomes. The BAF complex is known to colocalize with H3K4me1 in the genome 6 . Our data suggest that H3K4me1 may have a direct role in stabilizing BAF complex binding to chromatin. To investigate whether H3K4me1 can indeed serve to facilitate Supplementary Fig. 4c ). The reduced percentage of the top band was defined as remodeling efficiency. 
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binding of BAF complexes in the absence of other cofactors or transcription factors, we repeated the mononucleosome pulldown assays with BAF complex purified from HeLa cells ( Supplementary  Fig. 4a ). We found that purified BAF complex bound to H3K4me1 with higher affinity than H3K4me3 on mononucleosomes ( Fig. 5a ) and, to a lesser extent, histone H3 tail peptides ( Supplementary  Fig. 4b ). These data demonstrate that protein complexes can recognize and distinguish between closely related H3K4 methylation states, and this could be important for their recruitment to enhancers. The BAF complex regulates transcription by remodeling nucleosomes at sites of H3K4me1, suggesting a link between histone methylation and BAF activity. Using in vitro nucleosome remodeling assays 32 , we found that the BAF complex more efficiently remodels H3K4me1-marked mononucleosomes than mononucleosomes marked with H3K4me0, H3K4me2, or H3K4me3 (Fig. 5b,c and Supplementary Fig. 4c ). These data suggest a functional link between enhancer-specific histone modifications and the activity of recruited chromatin regulatory complexes.
Crystal structure of DPF3 binding preferentially to H3K4me1. On the basis of peptide binding and nuclear magnetic resonance (NMR)/X-ray structures, the PHD1 domain of BAF component DPF3 (BAF45C) recognizes H3K14ac, while the PHD2 domain in this protein binds to H3K4me0 33 . BAF subunits DPF1, DPF2, DPF3, and PHF10 (BAF45B, BAF45D, BAF45C, and BAF45A isoforms, respectively) have cell-type-specific expression patterns 34 . Our data demonstrate that mESC-specific DPF2 associates with H3K4me1.
To determine whether the DPF3 (BAF45C) PHD2 domain could contribute to H3K4me1 recognition as well, we purified the PHD1-PHD2 region of DPF3 from this family of proteins and used isothermal titration calorimetry to measure its affinity for histone H3 tail peptides containing H3K14ac plus H3K4me0, H3K4me1, or H3K4me3. Consistent with our biochemical studies, we found that the isolated DPF3 PHD1-PHD2 region strongly preferred binding of H3K4me1 (K d of 20 μM for H3K4me1/H3K14ac) over H3K4me3 (K d of 115 μM for H3K4me3/H3K14ac) ( Supplementary Fig. 5a-c) . However, in contrast to our findings with the intact BAF complex and mononucleosomes, the DPF3 PHD1-PHD2 region bound to the H3K4me0 peptide with slightly higher affinity (K d of 7.8 μM for H3K4me0/H3K14ac) than the H3K4me1 peptide. These data suggest that additional factors in the BAF complex and/or nucleosomes may influence H3K4me1 specificity.
To investigate the atomic basis of the preferential recognition by DPF3 PHD1-PHD2 of H3K4me1 over H3K4me3, we next determined two high-resolution (1.2-Å) crystal structures of the DPF3 PHD1-PHD2 region bound to histone H3 tail peptides (residues 1-18) containing H3K14ac and either H3K4me0 or H3K4me1 (Supplementary Table 3 ). The two structures showed a nearly identical overall structure of DPF3 (overall Cα rootmean-square deviation (r.m.s.d.) of <0.04 Å) and largely agreed with prior structures of this protein, with overall Cα r.m.s.d. of 1.5 Å to a prior NMR structure (PDB ID 2KWJ) and overall Cα r.m.s.d. of 0.8 Å to a prior X-ray crystal structure (PDB ID 5I3L) 17, 33 . In our two structures, the two PHD domains were intimately associated with one another, with a binding pocket in PHD1 that recognizes H3K14ac and a pocket in PHD2 that recognizes H3K4 (Fig. 6a-c) , leading to virtually identical bound conformations of the H3K4me0 and H3K4me1 peptides. In both complexes, H3K4 was nestled tightly in a surface cavity made up of the hydrophobic side chains of Ile314, Leu331, and Phe333. In addition, the main-chain carbonyl groups of residues 314, 315, and 317 were all close enough to the H3K4 amino group to form hydrogen-bonding interactions. These interactions likely contribute to the preferential binding of unmethylated or monomethylated H3K4, the amino groups of which can form two (H3K4me1) or three (H3K4me0) hydrogen bonds, over di-or trimethylated H3K4. In addition, the H3K4 monomethyl group was packed in a preformed cavity that is just large enough for a single methyl group. Hence, these carbonyl groups may sterically disfavor binding of di-or trimethylated H3K4.
In contrast to earlier NMR structures of the DPF3-histone H3 tail complex 33 , but in agreement with a recent crystal structure 17 , our structures show that histone H3 residues 4-10 adopt an α-helical conformation. Additionally, we found that H3R8 forms a 'lid' over the binding site, extending directly over H3K4 and forming a hydrogen-bonding network with DPF3 residues Glu315 and Asp328 on opposite sides of the H3K4 binding pocket (Fig. 6b,c and Supplementary Fig. 5d ,e); this residue's position was not well resolved in the previous crystal structure 17 . Both the α-helical conformation of the histone H3 tail and the H3R8 lid most closely mirror earlier observations in crystal structures of the MYST family acetyltransferase KAT6A (MOZ), which possesses a double-PHDfinger domain at its N terminus that recognizes unmodified H3K4 and acetylated H3K14 28 or propionylated, butyrylated, or crotonylated H3K14 35 . This H3-tail-binding mode may also be shared in other double-PHD-finger protein families; for instance, an unpublished NMR structure of KMT2C (PDB ID 2YSM) shows that this protein possesses a pair of acidic residues bracketing the H3K4 binding site that could participate in H3R8 binding (data not shown). This mode of H3K4 recognition may also have functional relevance, as it leaves the H3K4me1 methyl group solvent exposed in the complex, creating the possibility that additional factors in BAF or in the nucleosome itself could associate with the composite DPF3-H3K4me1 surface and provide additional specificity for H3K4me1 over H3K4me0.
Discussion
In summary, we carried out SILAC mass spectrometry analysis to systematically identify nuclear proteins that bind H3K4me1. Our experiments uncovered components of multiple chromatin regulatory complexes, including the BAF chromatin-remodeling complex, as H3K4me1-associating proteins. We further validated the binding of a subset of these complexes to H3K4me1-marked mononucleosomes in vitro and to genomic regions bearing the histone mark in mESCs. We showed that deletion of H3K4 methyltransferases KMT2C and KMT2D leads to a loss of occupancy by these complexes at KMT2C/D-dependent H3K4me1 regions. Notably, we confirmed that loss of H3K4me1 in both KMT2C/ D-knockout cells and cells with catalytically null mutants correlated with a decrease in binding of CRs to enhancers, supporting our hypothesis that H3K4me1 has an important role in binding of key chromatin regulatory factors. We chose to focus on the BAF complex and obtained strong evidence suggesting that H3K4me1 is directly involved in association of this complex to chromatin. The BAF complex belongs to the SWI/SNF family of ATP-dependent chromatin-remodeling complexes 34 . Containing between 10 and 12 components, BAF complexes are necessary for early embryogenesis, activation of lineage-specific genes during cellular differentiation, and maintenance of pluripotency in ESCs. Genome-wide profiling studies have shown that BAF complexes generally localize to distal enhancers, where they are required for histone acetylation during differentiation of ESCs. A recent study involving in situ capture of specific genomic regions also identified BAF as an enhancer-bound complex 36 . However, exactly how BAF complexes are recruited to enhancers is not fully understood 34 . Here we provided multiple lines of evidence that H3K4me1 may have a role in the recruitment of BAF complexes to enhancers. BAF complexes fail to localize to promoter-distal enhancers in KMT2C/D DKO cells as well as in cells with catalytically inactive KMT2C/D. Using protein pulldown assays, we showed that the BAF complex interacts directly with H3K4me1containing mononucleosome in vitro via the PHD2 domain Articles NAturE GENEtICS in DPF3 (BAF45C). X-ray crystallography experiments highlighted a surface cavity in the PHD2 domain of DPF3 that readily accommodates monomethylated Lys4 of histone H3, but not the trimethylated form. Finally, nucleosome-remodeling assays demonstrated that, above all other H3K4me states, H3K4me1 facilitates the BAF complex's nucleosome-remodeling activity. These results, taken together, support a model in which the histone modification H3K4me1 directly helps to recruit BAF complexes to enhancers and therefore has an active role in enhancer function.
While this work was under revision, Dorighi et al. 31 reported that KMT2C and KMT2D promote RNA synthesis at enhancers and nearby promoters independently of H3K4 monomethylation activities. While this observation suggests that H3K4me1 may not be necessary for loading of RNA polymerase II at enhancers and subsequent activation of target promoters, it does not rule out other functions for H3K4me1 at enhancers. Another recent study demonstrated that Drosophila melanogaster bearing catalytically inactive Trr (H3K4me1 histone methyltransferase) survive to adulthood with only subtle gene expression changes. However, when these flies were subjected to temperature stress conditions, developmental abnormalities were observed 37 . In addition, this and other studies have found that loss of KMT2C and KMT2D in mESCs does not affect self-renewal 16, 37 . This can be partially explained by the fact that, at poised enhancers in mESCs, H3K4 monomethylation is KMT2C/D independent 31 , suggesting a role for other methyltransferases in H3K4me1 deposition and enhancer function in higher organisms. This is in agreement with our current study demonstrating that ~50% of H3K4me1 peaks in mESCs are KMT2C/D independent. Therefore, additional experiments are needed to better define the role of H3K4me1 in enhancer function during cellular differentiation and animal development. 
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